Published in J Urol on December 14, 2009
Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer (2008) 4.77
Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. J Am Coll Surg (2013) 1.91
Effect of obesity on urethroplasty outcome. Urology (2009) 1.59
Management of severe urethral complications of prostate cancer therapy. J Urol (2006) 1.58
Major depression drives severity of American Urological Association Symptom Index. Urology (2010) 1.54
IPSS quality of life question: a possible indicator of depression among patients with lower urinary tract symptoms. Can J Urol (2012) 1.54
A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery. J Endourol (2014) 1.46
Patient misunderstanding of the individual questions of the American Urological Association symptom score. J Urol (2008) 1.46
Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications. J Urol (2011) 1.43
Endovascular management of trauma related renal artery thrombosis. J Trauma (2008) 1.43
Assessment of single-item literacy questions, age, and education level in the prediction of low health numeracy. JAAPA (2013) 1.42
Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma. Int J Urol (2014) 1.42
Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007. Prostate Cancer (2012) 1.38
Minimally invasive endovascular techniques to treat acute renal hemorrhage. J Urol (2008) 1.36
Safety and effectiveness of a new saline filled testicular prosthesis. J Urol (2004) 1.34
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology (2011) 1.30
Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv Anat Pathol (2008) 1.30
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28
Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol (2010) 1.26
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. Am J Nucl Med Mol Imaging (2013) 1.21
The efficacy of written screening tools in an inner city hospital: literacy based limitations on patient access to appropriate care. J Urol (2007) 1.17
Inherent difficulties of measuring the burden of surgical disease in resource-poor settings. World J Surg (2013) 1.07
Current trends in the molecular classification of renal neoplasms. ScientificWorldJournal (2006) 1.07
Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy. J Urol (2004) 1.06
Scrotal cancer survival is influenced by histology: a SEER study. World J Urol (2012) 0.99
Severe lack of comprehension of common prostate health terms among low-income inner-city men. Cancer (2013) 0.98
Nocturia associated with depressive symptoms. Urology (2011) 0.96
Assessment of the performance of the American Urological Association symptom score in 2 distinct patient populations. J Urol (2008) 0.95
Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database. Can J Urol (2013) 0.95
Videoscopic inguinal lymphadenectomy for metastatic melanoma. Cancer Control (2013) 0.92
Primary penile angiosarcoma in a patient with AIDS: a case report. AIDS (2007) 0.91
Penetrating external genital trauma: a 30-year single institution experience. J Urol (2008) 0.90
Improper retrograde urethrogram technique leads to incorrect diagnosis. J Urol (2009) 0.89
Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease. J Urol (2010) 0.89
Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep (2014) 0.88
Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma. Can J Urol (2012) 0.88
Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis. Am J Clin Oncol (2010) 0.87
Review of the relationship between C-reactive protein and exercise. Mol Diagn Ther (2011) 0.87
Systematic review of the evidence of a relationship between chronic psychosocial stress and C-reactive protein. Mol Diagn Ther (2013) 0.85
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiother Oncol (2008) 0.85
Association between smoking status, and free, total and percent free prostate specific antigen. J Urol (2012) 0.84
Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicopathologic study of 14 cases. Anal Quant Cytopathol Histpathol (2013) 0.84
Video-based educational tool improves patient comprehension of common prostate health terminology. Cancer (2014) 0.83
Medical student surgery elective in rural Haiti: a novel approach to satisfying clerkship requirements while providing surgical care to an underserved population. World J Surg (2011) 0.83
Minor symptoms are suggestive of metastatic renal cell carcinoma if c-reactive protein remains high after curative nephrectomy. J Clin Oncol (2010) 0.82
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer. Cancer (2013) 0.82
Multimedia version of a standard medical questionnaire improves patient understanding across all literacy levels. J Urol (2009) 0.82
Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology (2011) 0.81
The impact of income and education on dietary habits in stone formers. Urology (2010) 0.80
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis. Clin Transplant (2014) 0.80
Estimated volume growth characteristics of renal tumors undergoing active surveillance. Can J Urol (2010) 0.79
Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors. Can J Urol (2012) 0.79
Non-malignant drivers of elevated C-reactive protein levels differ in patients with and without a history of cancer. Mol Diagn Ther (2010) 0.79
Applying population dynamics modeling to patients with lymph node positive prostate cancer. J Urol (2007) 0.79
Health related quality of life significance of single pad urinary incontinence following radical prostatectomy. J Urol (2003) 0.79
Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT. Clin Nucl Med (2011) 0.79
Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma. Mol Imaging Biol (2011) 0.78
Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach. Can J Urol (2012) 0.78
Duplicated vena cava with tumor thrombus from renal cancer: use of venogram for safer operative planning. Urology (2011) 0.78
Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990-2009. Am J Public Health (2014) 0.78
Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma. Mol Diagn Ther (2011) 0.78
Prospective pilot study of smoking cessation in patients undergoing urologic surgery. Urology (2012) 0.78
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. Can J Urol (2015) 0.78
C-reactive protein may represent sensitive measure of renal cell carcinoma metastasis. Urol Nurs (2011) 0.77
Increased mortality among Hispanic testis cancer patients independent of neighborhood socioeconomic status: a SEER study. J Immigr Minor Health (2011) 0.77
Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. Int J Surg Oncol (2012) 0.77
International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Eur Urol (2011) 0.77
Learning from Haiti. Lancet (2011) 0.77
C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma. Mol Diagn Ther (2010) 0.76
Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol (2006) 0.76
Sensitive biomarkers of cancer recurrence and metastasis: inexpensive tools to cut costs and reduce radiation exposure among cancer patients. Mol Diagn Ther (2012) 0.76
Intensive medical student involvement in short-term surgical trips provides safe and effective patient care: a case review. BMC Res Notes (2011) 0.75
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer. Clin Nucl Med (2017) 0.75
Breakage of Needle during Intracavernosal Injection and Use of Portable Ultrasound Guidance for Removal. Case Rep Urol (2013) 0.75
Racial disparities in prostate cancer care: is adherence to National Comprehensive Cancer Network guidelines good enough for our patients? Cancer (2013) 0.75
Re: Lymphangiography with sclerotherapy: a novel therapy for refractory chylous ascites. Can J Urol (2012) 0.75
Decreased cancer survival in individuals separated at time of diagnosis: Critical period for cancer pathophysiology? Cancer (2010) 0.75
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity. Am J Clin Oncol (2009) 0.75
Surgery for high-risk prostate cancer and metastatic prostate cancer. Curr Probl Cancer (2014) 0.75
International surgical clerkship rotation: perceptions and academic performance. Am J Surg (2013) 0.75
C-reactive protein: a clinically useful biomarker in renal cell carcinoma. JAAPA (2012) 0.75
Radical nephrectomy via epidural-only anesthesia. Can J Urol (2010) 0.75
Extramammary Paget's disease in males: survival outcomes in 495 patients. Ann Surg Oncol (2014) 0.75
Intra-tumor Doppler flow patterns do not predict malignancy of renal masses in a United States population. Can J Urol (2011) 0.75
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis. Urol Int (2015) 0.75
A win for all: faculty-student partnerships in surgical humanitarianism. Bull Am Coll Surg (2013) 0.75
Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients. Tumour Biol (2010) 0.75
Pediatric adrenal trauma in the 21st century: Children's Hospital of Atlanta experience. J Urol (2011) 0.75
Hidden variables: why patients may misunderstand written screening tools. JAAPA (2011) 0.75
Appropriate use of CT in the diagnosis of bladder rupture. J Am Coll Surg (2005) 0.75
Extramammary Paget's Disease of genitourinary origin. Curr Opin Urol (2022) 0.75